[Federal Register Volume 74, Number 19 (Friday, January 30, 2009)]
[Notices]
[Pages 5648-5649]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-2034]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning Treatment 
of the CNS for Status Epilepticus Due to Organophosphate Exposure

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/104,311 entitled `` * * * Treatment of the CNS for Status 
Epilepticus Due to Organophosphate Exposure,'' filed October 10, 2008. 
The United States Government, as represented by the Secretary of the 
Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention is a method of post exposure 
treatment for chemical warfare nerve agent or organophosphate induced 
seizure/status epilepticus and neuropathology. The method of treatment 
utilizes a specific blood-brain

[[Page 5649]]

barrier penetrating oxime. The administration of this oxime initiates 
the reactivation of the central nervous system cholinesterases (AChE 
and BChE) for pesticide and OP induced central nervous system (and 
peripherally) inhibited AChE.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
 [FR Doc. E9-2034 Filed 1-29-09; 8:45 am]
BILLING CODE 3710-08-P